Metabolic Disease and Peripheral Neuropathy – Mechanistic Insights from Bench to Bedside

Metabolic diseases (obesity, pre-diabetes, diabetes, cardiometabolic disease) are the number one cause of peripheral neuropathies, but the underlying mechanisms leading to neurodegeneration remain unclear. This symposium brings together foundational, translational and clinical research updates from leaders in their fields to reveal novel mechanistic insights.

Speakers

Kristy Townsend, PhD, The Ohio State University, Columbus, OH, USA
Innervation of Adipose Tissues in Mouse and Human and Damage to Adipose Nerves with Obesity

Brian Callaghan, MD, University of Michigan, Ann Arbor, MI, USA
Obesity-related neuropathy in humans, a new epidemic

Christopher Gibbons, MD, Harvard Medical School, Beth Israel Deaconess, Cambridge, MA, USA
Incretin agonist drugs in the treatment of obesity: friend or foe for peripheral neuropathy?

REGISTER